SUSPENSION LETTER - MAILED
mailed
on 24 Jul 2024
Last Applicant/ Owned by
855 2nd Street S.W.
Calgary, Alberta
CA
T2P4J8
Serial Number
97182740 filed on 21st Dec 2021
Registration Number
N/A
Correspondent Address
Charles G. Zug
Charles G. Zug NELSON MULLINS RILEY & SCARBOROUGH LLP
SUITE 2300, IP DEPARTMENT
CHARLOTTE, NC 28202
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ALMOND THERAPY: TARGETING THE AMYGDALA
Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, c Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Psychotherapy services; mental health therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing temporary use of online, non-downloadable computer software for providing therapy services in the nature of scheduling and facilitating Internet-based patient and medical provider meetings to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; compilation of medical data for research purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [041]
Education and Entertainment Services
Provision of education in the nature of providing courses of instruction and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education in the nature of providing courses of instruction and training in the field of psychedelic medicines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [036]
Insurance & Financial Services
Compilation of medical data for financial purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Compilation for business purposes and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97182740
Mark Type
No Service Mark
Attorney Docket Number
No 070840/09001
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Nov 2024 | ASSIGNED TO EXAMINER |
| 24th Jul 2024 | LETTER OF SUSPENSION E-MAILED |
| 24th Jul 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 24th Jul 2024 | SUSPENSION LETTER WRITTEN |
| 20th Jul 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 20th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 20th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 22nd Apr 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 22nd Apr 2024 | INQUIRY TO SUSPENSION E-MAILED |
| 22nd Apr 2024 | SUSPENSION INQUIRY WRITTEN |